ENTITY
Pharmaessentia Corp

Pharmaessentia Corp (6446 TT)

124
Analysis
Health Care • Taiwan
PharmaEssentia Corporation develops and distributes therapeutic products for treatment in human disease. The Company develops drugs to treat hepatitis, chronic myeloid leukemia (CML), essential thrombocythemia (ET), myeloid fibrosis (MF), polycythemia vera (PV), hepatitis and cancer.
more
•28 Jan 2024 10:00

TWSE Foreign Holding Weekly (Jan 26th): TSMC, Alchip Tech, Pharmaessentia, Asmedia Tech, Umc

We analyzed TWSE foreign holding data for the past week and highlighted foreign holding changes in TSMC, Alchip Tech, Pharmaessentia, Asmedia Tech,...

Logo
564 Views
Share
•21 Jul 2023 20:05

Pharmaessentia Corp (6446 TT): Besremi Revenue Is Recovering; Fund Raising Through GDS Completed

Pharmaessentia reported record-high revenue of NT$509M for Jun’23, up 84% YoY and 22% MoM, driven by Besremi. The company raised $463M through GDS...

Logo
948 Views
Share
bullish•Rakuten Bank
•23 Apr 2023 07:25

ECM Weekly (23rd Apr 2023) - Rakuten Bank, Merdeka, ZJLD, Mankind, Lalatech, IMotion, Anta, KIT

Aequitas Research puts out a weekly update on the deals that were covered by the team recently along with updates for upcoming IPOs.

Logo
627 Views
Share
bullish•Rakuten Bank
•16 Apr 2023 10:00

ECM Weekly (16th Apr 2023) - Rakuten Bank, Harita Nickel, Merdeka Battery, ZJLD, Adicon, Supcon

Aequitas Research puts out a weekly update on the deals that were covered by the team recently along with updates for upcoming IPOs.

Logo
534 Views
Share
x